The National Drug Authority participated in the 1st African Medicines Agency (AMA) Joint Review of an Ebola Clinical Trial Protocol, a four-day workshop at Kampala Sheraton.
Jointly organized by AMA, UNCST, and NDA with support from CEPI, the workshop brought together representatives from Ethiopian FDA, NAFDAC, Rwanda FDA, UNHRO, UVRI-REC, and other regulatory and research institutions to strengthen clinical trial protocol review and preparedness for public health emergencies.
